This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
pl pro | 173 |
respiratory syndrome | 140 |
acute respiratory | 118 |
cov pl | 101 |
severe acute | 100 |
syndrome coronavirus | 84 |
cell culture | 79 |
influenza virus | 67 |
infl uenza | 60 |
epithelial cells | 59 |
virus infection | 57 |
type i | 55 |
hcv ns | 54 |
immune response | 51 |
novel coronavirus | 49 |
avian influenza | 47 |
respiratory tract | 46 |
viral rna | 45 |
cp therapy | 43 |
hemorrhagic fever | 41 |
middle east | 40 |
east respiratory | 40 |
innate immune | 40 |
pregnant women | 39 |
cord uid | 39 |
sin doi | 39 |
doc id | 39 |
virol sin | 39 |
stress granule | 38 |
viral load | 38 |
stress granules | 36 |
ifn production | 34 |
viral replication | 33 |
vaccinia virus | 33 |
influenza viruses | 32 |
dengue virus | 32 |
cell lines | 32 |
recombinant vaccinia | 32 |
immune responses | 31 |
respiratory disease | 30 |
lung injury | 29 |
sg formation | 29 |
like protease | 29 |
sars coronavirus | 29 |
public health | 28 |
culture models | 28 |
cov infection | 28 |
infectious diseases | 27 |
inflammatory responses | 26 |
saudi arabia | 26 |
ad cells | 26 |
nucleic acid | 26 |
adenovirus type | 25 |
resplex ii | 25 |
i ifn | 24 |
raft cultures | 24 |
hantavirus infection | 24 |
ln group | 24 |
cell epitopes | 24 |
infected cells | 24 |
life cycle | 23 |
highly pathogenic | 23 |
cr kptecs | 23 |
seasonal influenza | 23 |
animal models | 23 |
gene expression | 23 |
rna viruses | 22 |
innate immunity | 22 |
hexon gene | 22 |
monoclonal antibodies | 22 |
protein kinase | 22 |
vaccinia viruses | 22 |
granule formation | 21 |
disease severity | 21 |
en group | 21 |
cell cultures | 21 |
convalescent plasma | 21 |
coronavirus disease | 21 |
rabies virus | 21 |
risk factors | 20 |
vero cells | 20 |
virus replication | 20 |
human adenovirus | 20 |
infected patients | 20 |
converting enzyme | 19 |
viral infection | 19 |
lower respiratory | 19 |
neutralizing antibody | 19 |
epidemic hemorrhagic | 19 |
clinical features | 18 |
crystal structure | 18 |
host cells | 18 |
ub complex | 18 |
simplex virus | 18 |
culture system | 18 |
herpes simplex | 18 |
human papillomavirus | 18 |
organotypic raft | 18 |
ag mice | 18 |
prolonged positivity | 18 |
antiviral response | 18 |
mice immunized | 18 |
human coronavirus | 17 |
authors declare | 17 |
weight loss | 17 |
culture systems | 17 |
coronavirus infection | 17 |
uenza virus | 17 |
renal syndrome | 17 |
spike protein | 17 |
cell line | 16 |
post infection | 16 |
ns protein | 16 |
lung tissues | 16 |
important role | 16 |
antiviral drugs | 16 |
infectious disease | 16 |
host innate | 15 |
innate antiviral | 15 |
vaccine strain | 15 |
human viruses | 15 |
cellular immune | 15 |
monoclonal antibody | 15 |
diarrhea virus | 15 |
epidemic diarrhea | 15 |
hong kong | 15 |
porcine epidemic | 15 |
neutralizing antibodies | 14 |
day post | 14 |
tiantan strain | 14 |
virologica sinica | 14 |
ebola virus | 14 |
acute lung | 14 |
binding protein | 14 |
ace protein | 14 |
previous studies | 14 |
ev infection | 14 |
early warning | 13 |
rna granules | 13 |
i interferon | 13 |
zika virus | 13 |
hepatitis virus | 13 |
health organization | 13 |
negative group | 13 |
amino acids | 13 |
world health | 13 |
supplementary material | 13 |
swine influenza | 13 |
stranded rna | 13 |
may also | 13 |
genomic dna | 13 |
processing bodies | 13 |
multiplex pcr | 12 |
confirmed cases | 12 |
reverse transcription | 12 |
epithelial raft | 12 |
clinical symptoms | 12 |
hydrogen bond | 12 |
inflammatory cytokines | 12 |
mammalian cells | 12 |
camel milk | 12 |
upper respiratory | 12 |
rna interference | 12 |
pathogenic avian | 12 |
gene therapy | 12 |
structural proteins | 12 |
multiplex rt | 12 |
amino acid | 12 |
taqman rt | 12 |
results showed | 12 |
cytopathic effect | 12 |
translation initiation | 12 |
host cell | 12 |
plasma therapy | 12 |
human coronaviruses | 11 |
seasonal infl | 11 |
porcine respiratory | 11 |
two viruses | 11 |
syncytial virus | 11 |
rnai suppression | 11 |
immune cells | 11 |
dna viruses | 11 |
respiratory syncytial | 11 |
viral loads | 11 |
primary human | 11 |
human respiratory | 11 |
symptom onset | 11 |
swine infl | 11 |
recombinant vaccine | 11 |
two viral | 11 |
immune system | 11 |
infectious virus | 11 |
host interactions | 11 |
influenza vaccine | 11 |
case report | 11 |
viral pathogens | 11 |
pulmonary edema | 11 |
raft culture | 11 |
cells infected | 11 |
receptor binding | 11 |
viral variants | 11 |
disease complex | 11 |
homologous recombination | 11 |
type ii | 11 |
vsr activity | 10 |
recombinant plasmid | 10 |
two patients | 10 |
extracted using | 10 |
positive farms | 10 |
porcine circovirus | 10 |
clinical manifestations | 10 |
antibody response | 10 |
viral proteins | 10 |
binding proteins | 10 |
ill patients | 10 |
influenza vaccines | 10 |
coronavirus papain | 10 |
days post | 10 |
avian infl | 10 |
animal subjects | 10 |
northern blotting | 10 |
rights statement | 10 |
tissue engineering | 10 |
infection model | 10 |
widely used | 10 |
coronavirus associated | 10 |
hela cells | 10 |
human rights | 10 |
tract infections | 10 |
antibody titer | 10 |
drug discovery | 10 |
pcr amplification | 10 |
genome sequence | 10 |
clinical characteristics | 10 |
dimensional cell | 10 |
multiparous sows | 10 |
suppress rnai | 10 |
mouse hepatitis | 9 |
severe covid | 9 |
emerging human | 9 |
human cells | 9 |
accessory proteins | 9 |
within days | 9 |
critically ill | 9 |
organotypic epithelial | 9 |
fusion protein | 9 |
way anova | 9 |
western blot | 9 |
hantavirus infections | 9 |
distress syndrome | 9 |
subjects performed | 9 |
mice infected | 9 |
proximal tubule | 9 |
hantavirus pulmonary | 9 |
weeks old | 9 |
binding site | 9 |
pcr products | 9 |
respiratory distress | 9 |
pulmonary syndrome | 9 |
recombinant adenovirus | 9 |
lung tissue | 9 |
risk factor | 9 |
hexon protein | 9 |
antiviral agents | 9 |
disease control | 9 |
nps specimens | 9 |
antibody responses | 9 |
bronchial epithelial | 9 |
large number | 9 |
granule assembly | 9 |
cancer cell | 9 |
specific shrna | 9 |
conditional reprogramming | 9 |
suppression activity | 9 |
cell entry | 8 |
clinical samples | 8 |
molecular epidemiology | 8 |
time points | 8 |
antibody titers | 8 |
tissue culture | 8 |
cancer cells | 8 |
cell responses | 8 |
test results | 8 |
respiratory viruses | 8 |
chinese academy | 8 |
emerging infectious | 8 |
dub activity | 8 |
survival rate | 8 |
nonstructural proteins | 8 |
virus strains | 8 |
western blotting | 8 |
two cases | 8 |
host range | 8 |
respiratory specimens | 8 |
coronavirus spike | 8 |
specific humoral | 8 |
fatality rate | 8 |
vaccine candidate | 8 |
statistically significant | 8 |
recent progress | 8 |
hiv infection | 8 |
natural science | 8 |
viral infections | 8 |
ct value | 8 |
initiation factor | 8 |
human ubiquitin | 8 |
nucleocapsid protein | 8 |
mortality rate | 8 |
cells cultured | 8 |
long term | 8 |
cells expressing | 8 |
wuhan city | 8 |
adenovirus vaccine | 8 |
significant differences | 8 |
viral particles | 8 |
valley fever | 8 |
prdc presentation | 8 |
nonstructural protein | 8 |
uenza viruses | 8 |
new coronavirus | 8 |
rift valley | 8 |
length np | 8 |
serologic test | 8 |
human infections | 8 |
statistical analysis | 8 |
pediatric inpatients | 8 |
united states | 8 |
viral entry | 8 |
recent years | 8 |
culture model | 8 |
virus tiantan | 8 |
adaptive immune | 8 |
science foundation | 8 |
hepatocellular carcinoma | 8 |
universal influenza | 8 |
arms race | 8 |
denv infection | 8 |
target cells | 8 |
cov orf | 7 |
time pcr | 7 |
epithelial cell | 7 |
viral genomic | 7 |
human transmission | 7 |
specific antibodies | 7 |
rna helicase | 7 |
differentiation potential | 7 |
different species | 7 |
binding domain | 7 |
south korea | 7 |
bl loop | 7 |
human keratinocytes | 7 |
rna silencing | 7 |
nucleic acids | 7 |
host interaction | 7 |
human infection | 7 |
protein expression | 7 |
rnai pathway | 7 |
core protein | 7 |
vaccine development | 7 |
present study | 7 |
nucleotide sequence | 7 |
antiviral immunity | 7 |
alveolar macrophages | 7 |
inflammatory cells | 7 |
virus titer | 7 |
severe disease | 7 |
even though | 7 |
human liver | 7 |
early negative | 7 |
lentiviruses pseudotyped | 7 |
suspected cases | 7 |
hajj pilgrims | 7 |
mainland china | 7 |
lethal infection | 7 |
infected people | 7 |
closely related | 7 |
disease virus | 7 |
functional receptor | 7 |
human immunodeficiency | 7 |
immunodeficiency virus | 7 |
respiratory viral | 7 |
different groups | 7 |
lamp assay | 7 |
ascitic fluid | 7 |
rna binding | 7 |
control measures | 7 |
papillomavirus type | 7 |
fcr activation | 7 |
like proteases | 7 |
protease inhibitor | 7 |
clinical course | 7 |
raw camel | 7 |
total rna | 7 |
nk cells | 7 |
antiviral activity | 7 |
considered statistically | 7 |
authorized users | 7 |
egfp mrna | 7 |
codon usage | 7 |
cov nsp | 7 |
southern china | 7 |
viral genome | 7 |
acid test | 7 |
complete hexon | 7 |
viral life | 7 |
protein response | 7 |
ex vivo | 7 |
severe lung | 7 |
well plates | 7 |
dengue viruses | 7 |
antiviral drug | 7 |
isatin derivatives | 7 |
years old | 7 |
circovirus type | 7 |
inclusion bodies | 7 |
unfolded protein | 7 |
black arrow | 7 |
positive control | 7 |
th day | 7 |
mouse models | 7 |
mouth disease | 7 |
virus disease | 6 |
porcine reproductive | 6 |
ct images | 6 |
necrosis factor | 6 |
viral hepatitis | 6 |
drug design | 6 |
virus strain | 6 |
transmembrane domain | 6 |
biological evaluation | 6 |
high levels | 6 |
pcr assays | 6 |
virus culture | 6 |
nsp nsp | 6 |
nervous system | 6 |
two different | 6 |
previous study | 6 |
normal human | 6 |
lg ml | 6 |
mrna levels | 6 |
protease inhibitors | 6 |
genomic rna | 6 |
coronavirus nsp | 6 |
novel avian | 6 |
ub complexes | 6 |
mouse model | 6 |
infection induces | 6 |
dengue viral | 6 |
women infected | 6 |
actinobacillus pleuropneumoniae | 6 |
syndrome virus | 6 |
tumor necrosis | 6 |
saudi moh | 6 |
first time | 6 |
may play | 6 |
significantly higher | 6 |
online version | 6 |
strain gz | 6 |
total rnas | 6 |
viruses including | 6 |
cell interactions | 6 |
virus type | 6 |
viral diseases | 6 |
bronchiolar epithelial | 6 |
second immunization | 6 |
i ifns | 6 |
reverse transcriptase | 6 |
cj mice | 6 |
vaccine production | 6 |
severe critical | 6 |
patients infected | 6 |
gingival epithelium | 6 |
sendai virus | 6 |
hospitalized children | 6 |
bamh i | 6 |
rna polymerase | 6 |
fusion antigen | 6 |
iv gtt | 6 |
measured using | 6 |
may provide | 6 |
model systems | 6 |
inhibitory effects | 6 |
alveolar septum | 6 |
rna virus | 6 |
infected mice | 6 |
protein inhibits | 6 |
severe clinical | 6 |
human kidney | 6 |
late negative | 6 |
purified ace | 6 |
th th | 6 |
protective immunity | 6 |
described previously | 6 |
pathological changes | 6 |
deficient mice | 6 |
ifn receptor | 6 |
cytokine storm | 6 |
observational study | 6 |
kidney injury | 6 |
vascular leakage | 6 |
alveolar cells | 6 |
pooled peptides | 6 |
laboratory diagnosis | 6 |
see text | 6 |
ubl domain | 6 |
three times | 6 |
cov papain | 6 |
specimens collected | 6 |
chronic diseases | 6 |
mg ml | 6 |
recent study | 6 |
encoding egfp | 6 |
murine coronavirus | 6 |
protein involved | 6 |
cell immunity | 6 |
igg antibodies | 6 |
previously described | 6 |
sequence analysis | 6 |
analysis showed | 6 |
phylogenetic analysis | 6 |
time taqman | 6 |
respiratory virus | 6 |
antiviral immune | 6 |
balb cj | 6 |
term culture | 6 |
igg antibody | 6 |
wild birds | 6 |
contains supplementary | 6 |
health care | 6 |
enp induced | 6 |
incubation period | 6 |
substrate specificity | 6 |
ace expression | 6 |
world society | 6 |
studies showed | 6 |
hcv infection | 6 |
tubule cells | 6 |
viral gene | 6 |
evans blue | 6 |
clinical outcomes | 6 |
host antiviral | 6 |
virus vaccine | 6 |
plasmids encoding | 6 |
accessory protein | 6 |
early stage | 6 |
like receptors | 6 |
electronic supplementary | 6 |
time rt | 6 |
associated coronavirus | 6 |
traditional chinese | 6 |
fusion gene | 6 |
transmissible gastroenteritis | 6 |
chain amide | 6 |
expression system | 6 |
higher levels | 6 |
sg assembly | 6 |
adaptive immunity | 6 |
quantitative rt | 5 |
human covs | 5 |
significantly different | 5 |
wall vessel | 5 |
essential role | 5 |
dna damage | 5 |
human beings | 5 |
laboratory tests | 5 |
virus subtypes | 5 |
coronavirus infections | 5 |
infected animals | 5 |
ct scans | 5 |
mononuclear cells | 5 |
three patients | 5 |
xho i | 5 |
virus infections | 5 |
pcr product | 5 |
mycoplasma hyopneumoniae | 5 |
genome encodes | 5 |
structural basis | 5 |
qiagen resplex | 5 |
departing pilgrims | 5 |
incidence rate | 5 |
infected individuals | 5 |
cellular factors | 5 |
respiratory pathogens | 5 |
genotypes detected | 5 |
viral shedding | 5 |
oxide synthase | 5 |
chronic hepatitis | 5 |
chain reaction | 5 |
cell response | 5 |
general population | 5 |
korean hemorrhagic | 5 |
ethics committee | 5 |
significantly associated | 5 |
cell death | 5 |
foci forming | 5 |
vitro cell | 5 |
clinical isolate | 5 |
fetal bovine | 5 |
nsp genes | 5 |
class i | 5 |
early stages | 5 |
substrate binding | 5 |
human adenoviruses | 5 |
defective hadv | 5 |
green fluorescence | 5 |
infectious viral | 5 |
canine kidney | 5 |
like structures | 5 |
central nervous | 5 |
bat sl | 5 |
bovine serum | 5 |
factors associated | 5 |
cl protease | 5 |
antiviral innate | 5 |
whether hcv | 5 |
novel human | 5 |
antiviral compounds | 5 |
ifn induction | 5 |
kinase pkr | 5 |
block fcr | 5 |
cells using | 5 |
conditionally reprogrammed | 5 |
also demonstrated | 5 |
pp ab | 5 |
specific antibody | 5 |
binding affinity | 5 |
host mrna | 5 |
cell surface | 5 |
structure genes | 5 |
virus monoclonal | 5 |
viral culture | 5 |
cell types | 5 |
informed consent | 5 |
induces formation | 5 |
respiratory failure | 5 |
containing fbs | 5 |
suppress ifn | 5 |
vs rvj | 5 |
jinyintan hospital | 5 |
induced significantly | 5 |
inhibitory activity | 5 |
investigate whether | 5 |
reading frame | 5 |
viral rnas | 5 |
plasmid pet | 5 |
adenovirus vectors | 5 |
ace receptor | 5 |
viral pathogenesis | 5 |
newly discovered | 5 |
immunized mice | 5 |
cells grown | 5 |
rna replication | 5 |
viral protein | 5 |
studying human | 5 |
severe illness | 5 |
cervical cancer | 5 |
neutralization test | 5 |
coronavirus hku | 5 |
goat anti | 5 |
temporal profile | 5 |
gamma globulin | 5 |
negative control | 5 |
patients might | 5 |
infect humans | 5 |
clinical analysis | 5 |
pandemic influenza | 5 |
cov pathogenesis | 5 |
ii ifn | 5 |
female patient | 5 |
human cases | 5 |
zoster virus | 5 |
penton base | 5 |
seven isolates | 5 |
qpcr assays | 5 |
viruses causing | 5 |
rotavirus infection | 5 |
viruses genotypes | 5 |
national natural | 5 |
virus may | 5 |
viral nucleic | 5 |
coronavirus pneumonia | 5 |
infection models | 5 |
total nucleic | 5 |
different cell | 5 |
human influenza | 5 |
tubule epithelial | 5 |
global health | 5 |
cr cells | 5 |
bacterial agents | 5 |
neurogenic pulmonary | 5 |
human viral | 5 |
viral dna | 5 |
spike proteins | 5 |
viral growth | 5 |
human sars | 5 |
dna sequencing | 5 |
cohort study | 5 |
empty vector | 5 |
retrospective study | 5 |
transmission dynamics | 5 |
ace mrna | 5 |
analyzed using | 5 |
virus ns | 5 |
cov replication | 5 |
eukaryotic translation | 5 |
puumala virus | 5 |
key role | 5 |
higher frequencies | 5 |
mosquito cells | 5 |
functional characterization | 5 |
adenovirus vector | 5 |
feeder cells | 5 |
inhibits hiv | 5 |
different covs | 5 |
highly contagious | 5 |
older age | 5 |
viral clearance | 5 |
severe respiratory | 5 |
significant risk | 5 |
might also | 5 |
rabbit anti | 5 |
sg components | 5 |
drug development | 5 |
innate immunosuppressive | 5 |
human disease | 5 |
host responses | 5 |
close contact | 5 |
serum samples | 5 |
kidney proximal | 5 |
gastrointestinal symptoms | 5 |
specific sfcs | 5 |
eif alpha | 5 |
dependent rna | 5 |
serum antibody | 5 |
luciferase activity | 5 |
fusion antigens | 5 |
well plate | 5 |
also detected | 5 |
santa cruz | 5 |
final manuscript | 5 |
hospital stay | 5 |
monoplex real | 5 |
limited number | 5 |
cell model | 5 |
dna polymerase | 5 |
fever virus | 5 |
viral genes | 5 |
virus induces | 5 |
oxyanion hole | 5 |
pb components | 5 |
ub binding | 5 |
median ct | 5 |
host immune | 5 |
determine whether | 5 |
among groups | 5 |
case fatality | 5 |
ns gene | 5 |
national health | 5 |
activated protein | 5 |
infectious agents | 5 |
indirect immunofluorescence | 5 |
stress response | 5 |
mouse igg | 5 |
nitric oxide | 5 |
human cytomegalovirus | 5 |
htnv seov | 5 |
data showed | 5 |
different disease | 5 |
new york | 5 |
covalent complex | 5 |
entry efficiency | 5 |
antiviral rnai | 5 |
organ failure | 5 |
transgenic mice | 5 |
fatality risk | 5 |
reference standard | 5 |
kptecs using | 5 |
one day | 5 |
pb proteins | 5 |
forming assay | 5 |
virus titers | 5 |
medical university | 5 |
pregnant woman | 5 |
plasmid encoding | 5 |
conserved epitopes | 5 |
facilitates viral | 4 |
lactate dehydrogenase | 4 |
correlated significantly | 4 |
simultaneous detection | 4 |
inflammatory response | 4 |
monoplex rt | 4 |
hcv replication | 4 |
limited infection | 4 |
female balb | 4 |
committee meeting | 4 |
viral strains | 4 |
electron microscopy | 4 |
magnetic levitation | 4 |
neutralizing activity | 4 |
causing ards | 4 |
viruses also | 4 |
novel mechanism | 4 |
angiotensin converting | 4 |
culture supernatant | 4 |
phylogenetic trees | 4 |
wuhan university | 4 |
cov spike | 4 |
virus isolated | 4 |
high level | 4 |
kinetic assays | 4 |
intravenous immunoglobulin | 4 |
papainlike protease | 4 |
respiratory diseases | 4 |
open reading | 4 |
body weight | 4 |
soft agar | 4 |
interspecies transmission | 4 |
species transmission | 4 |
covs might | 4 |
zoonotic viruses | 4 |
infection causes | 4 |
clinical severity | 4 |
i ii | 4 |
lymphocyte count | 4 |
differences among | 4 |
lethal dose | 4 |
free pl | 4 |
still limited | 4 |
ion channel | 4 |
molecular basis | 4 |
dimensional culture | 4 |
plasmid pjsc | 4 |
human bocaviruses | 4 |
mammalian stress | 4 |
repair dna | 4 |
inhibition test | 4 |
using two | 4 |
strand rna | 4 |
inhibitors targeting | 4 |
directly bind | 4 |
specific cellular | 4 |
disease caused | 4 |
promotes cell | 4 |
data suggest | 4 |
health commission | 4 |
model using | 4 |
virion host | 4 |
chinese medicine | 4 |
endonucleolytic cleavage | 4 |
linked sialic | 4 |
functional motif | 4 |
two variants | 4 |
positive rates | 4 |
protein interacts | 4 |
flow bioreactor | 4 |
type vaccine | 4 |
direct contact | 4 |
sulfonyl isatin | 4 |
cov genome | 4 |
pathogenic human | 4 |
mediated inflammatory | 4 |
authors read | 4 |
may cause | 4 |
hcv nonstructural | 4 |
largely unknown | 4 |
pseudotyped viruses | 4 |
antiviral responses | 4 |
cov cases | 4 |
novel approach | 4 |
polymerase chain | 4 |
cells transfected | 4 |
antiviral effects | 4 |
cell rna | 4 |
four copies | 4 |
using pcr | 4 |
blood samples | 4 |
serious public | 4 |
cr condition | 4 |
bat origin | 4 |
physiologically relevant | 4 |
human papillomaviruses | 4 |
gapdh mrna | 4 |
human health | 4 |
vivo model | 4 |
acid amplification | 4 |
respiratory system | 4 |
plus panel | 4 |
different plaque | 4 |
seven viruses | 4 |
binding activities | 4 |
two groups | 4 |
ii plus | 4 |
lamp method | 4 |
clinical outcome | 4 |
better understanding | 4 |
taken together | 4 |
provide new | 4 |
loads determined | 4 |
four coronaviruses | 4 |
also increased | 4 |
hemagglutination inhibition | 4 |
modified vaccinia | 4 |
human ace | 4 |
terminal domain | 4 |
pcr kit | 4 |
gene silencing | 4 |
structural protein | 4 |
even death | 4 |
binding sites | 4 |
factor alpha | 4 |
host restriction | 4 |
old female | 4 |
coronavirus receptor | 4 |
primary gingival | 4 |
multiple functions | 4 |
human metapneumovirus | 4 |
human airway | 4 |
ev antigen | 4 |
isothermal amplification | 4 |
early diagnosis | 4 |
cancer research | 4 |
enzymatic activity | 4 |
nsp protein | 4 |
rna probe | 4 |
infected pregnant | 4 |
alveolar space | 4 |
panel pre | 4 |
peripheral blood | 4 |
cause severe | 4 |
surrounding tissues | 4 |
host gene | 4 |
ifn responses | 4 |
reverse genetics | 4 |
pig farms | 4 |
humoral immunity | 4 |
site cys | 4 |
including lungs | 4 |
induced rnai | 4 |
respiratory illness | 4 |
deubiquitinating activity | 4 |
research program | 4 |
cells well | 4 |
common cold | 4 |
pkr activation | 4 |
mers cases | 4 |
graphpad prism | 4 |
kidney functions | 4 |
saudi arabian | 4 |
mouse anti | 4 |
interferon antagonist | 4 |
hiv aids | 4 |
human normal | 4 |
restriction enzyme | 4 |
mild moderate | 4 |
dendritic cells | 4 |
expression level | 4 |
spleen cells | 4 |
bat coronaviruses | 4 |
human diseases | 4 |
viral dsrna | 4 |
scientific research | 4 |
data indicated | 4 |
covalent mers | 4 |
acute kidney | 4 |
previously known | 4 |
viral antigen | 4 |
mouse sera | 4 |
gene source | 4 |
severe cases | 4 |
review summarizes | 4 |
ev receptor | 4 |
diagnostic system | 4 |
probe targeting | 4 |
viruses using | 4 |
molecular mechanisms | 4 |
hypertensive covid | 4 |
negative farms | 4 |
type strain | 4 |
study also | 4 |
loading control | 4 |
negative controls | 4 |
viral suppressor | 4 |
alpha phosphorylation | 4 |
irf activation | 4 |
persistent viral | 4 |
catalytic efficiency | 4 |
rvf outbreak | 4 |
intermediate hosts | 4 |
unpasteurized camel | 4 |
shed light | 4 |
pfu denv | 4 |
internal proteins | 4 |
via northern | 4 |
highly conserved | 4 |
viral proteases | 4 |
epithelial tissue | 4 |
reduce mortality | 4 |
rna synthesis | 4 |
laboratory animal | 4 |
host shutoff | 4 |
stem cell | 4 |
odds ratio | 4 |
prevent virus | 4 |
ncov infection | 4 |
identifi ed | 4 |
differentiated human | 4 |
monitored daily | 4 |
seven days | 4 |
warning models | 4 |
first identified | 4 |
assisted diagnostic | 4 |
retrospective observational | 4 |
transcription factors | 4 |
new human | 4 |
avian coronaviruses | 4 |
matrix protein | 4 |
rapid antigen | 4 |
alkaline phosphatase | 4 |
renal failure | 4 |
increased risk | 4 |
virus transmission | 4 |
turned negative | 4 |
virus challenge | 4 |
established long | 4 |
cell biology | 4 |
icu admission | 4 |
thawed three | 4 |
lineage function | 4 |
pcr sensitivities | 4 |
imported case | 4 |
synonymous codon | 4 |
molecular biology | 4 |
pshuttle plasmid | 4 |
pandemic virus | 4 |
sp viruses | 4 |
stimulated gene | 4 |
examine whether | 4 |
sialic acids | 4 |
cell lysates | 4 |
cell strains | 4 |
miscellaneous conditions | 4 |
barr virus | 4 |
see whether | 4 |
sequence identity | 4 |
days later | 4 |
cell tropisms | 4 |
epidemiological studies | 4 |
written informed | 4 |
mrna decay | 4 |
one year | 4 |
results indicate | 4 |
treatment may | 4 |
three major | 4 |
coli system | 4 |
ct scan | 4 |
antibody test | 4 |
na proteins | 4 |
double knock | 4 |
antibody tests | 4 |
monoplex taqman | 4 |
ethical standards | 4 |
proteintech group | 4 |
available data | 4 |
rna sequencing | 4 |
basic cell | 4 |
author contributions | 4 |
tract infection | 4 |
copy number | 4 |
control virus | 4 |
mers patients | 4 |
epsilon epitope | 4 |
control efforts | 4 |
nt sirna | 4 |
renal proximal | 4 |
dimensional tissue | 4 |
young children | 4 |
adenoviral respiratory | 4 |
causing severe | 4 |
future studies | 4 |
arg forms | 4 |
complete genome | 4 |
newly identified | 4 |
significant difference | 4 |
virus rna | 4 |
cell apoptosis | 4 |
respiratory infections | 4 |
van duinen | 4 |
humoral immune | 4 |
clinical information | 4 |
significant impact | 4 |
receptor ace | 4 |
ct values | 4 |
alexa fluor | 4 |
rna decay | 4 |
signaling pathways | 4 |
coronavirus nonstructural | 4 |
viral envelope | 4 |
prospectively collected | 4 |
isolated viruses | 4 |
labeled rna | 4 |
active site | 4 |
first committee | 4 |
kidney cells | 4 |
severe pneumonia | 4 |
parainfluenza virus | 4 |
different stages | 4 |
previously reported | 4 |
responses induced | 4 |
examined via | 4 |
gastroenteritis virus | 4 |
normal cells | 4 |
underlying mechanism | 4 |
infect cells | 4 |
extraction kit | 4 |
potential therapeutic | 4 |
literature review | 4 |
emergent human | 4 |
peritoneal cavity | 4 |
safety evaluation | 4 |
moving average | 4 |
reported cases | 4 |
myeloma cells | 3 |
ccl cells | 3 |
novel viruses | 3 |
copies per | 3 |
recent advances | 3 |
standard strains | 3 |
reaction buffer | 3 |
similar results | 3 |
remains elusive | 3 |
pedv strains | 3 |
binding patterns | 3 |
well studied | 3 |
usage bias | 3 |
protective immune | 3 |
high viral | 3 |
deubiquitinating activities | 3 |
main chain | 3 |
fi eld | 3 |
hiv protease | 3 |
current understanding | 3 |
proteolytic processing | 3 |
pb formation | 3 |
mrna transcripts | 3 |
continuous passages | 3 |
potential platform | 3 |
heart disease | 3 |
like illness | 3 |
moh website | 3 |
rapid assessment | 3 |
cases co | 3 |
prolonged viral | 3 |
ii pneumocytes | 3 |
dependent enhancement | 3 |
ns contains | 3 |
cell migration | 3 |
stimulated genes | 3 |
study group | 3 |
newly emerging | 3 |
many viruses | 3 |
control program | 3 |
vaccine strains | 3 |
remains unclear | 3 |
immune evasion | 3 |
gingival keratinocytes | 3 |
recognition receptors | 3 |
hiv infected | 3 |
monkey kidney | 3 |
sequestrating dsrna | 3 |
england biolabs | 3 |
data suggested | 3 |
influenza infection | 3 |
trizol reagent | 3 |
deisgylating activity | 3 |
cell science | 3 |
risk hpv | 3 |
vaccine vector | 3 |
numbering scheme | 3 |
dengue disease | 3 |
natural reservoir | 3 |
methyltransferase activity | 3 |
laboratory findings | 3 |
immortalized human | 3 |
facilitate virus | 3 |
like domains | 3 |
ifn deficient | 3 |
among humans | 3 |
positive cells | 3 |
modelling study | 3 |
gel electrophoresis | 3 |
independent growth | 3 |
may differ | 3 |
ifn expression | 3 |
using trizol | 3 |
coronavirus nucleocapsid | 3 |
membrane fusion | 3 |
late pregnancy | 3 |
time series | 3 |
labeled dsrna | 3 |
ns protease | 3 |
cell signaling | 3 |
medical conditions | 3 |
cov nsps | 3 |
provide insights | 3 |
receptor recognition | 3 |
pcr method | 3 |
model system | 3 |
constructed based | 3 |
immortalized cell | 3 |
hypertensive ones | 3 |
mrna cap | 3 |
various mechanisms | 3 |
rna recognition | 3 |
virus rvj | 3 |
transcription factor | 3 |
viral host | 3 |
liver cancer | 3 |
confidence interval | 3 |
day prior | 3 |
airway epithelia | 3 |
human renal | 3 |
target different | 3 |
heterologous influenza | 3 |
may contribute | 3 |
protein binds | 3 |
cellular proteins | 3 |
comparative analysis | 3 |
virus virion | 3 |
evaluating antiviral | 3 |
competing interest | 3 |
progeny virus | 3 |
egfp orf | 3 |
much stronger | 3 |
key risk | 3 |
farms positive | 3 |
two hcovs | 3 |
fusion genes | 3 |
crystal structures | 3 |
sequence alignments | 3 |
biological activity | 3 |
plaque sizes | 3 |
signaling pathway | 3 |
induces robust | 3 |
comparative genomic | 3 |
serine protease | 3 |
darby canine | 3 |
human neural | 3 |
various cov | 3 |
effective control | 3 |
recently developed | 3 |
treatment period | 3 |
van kerkhove | 3 |
causes severe | 3 |
group leaders | 3 |
virus nucleoprotein | 3 |
results suggested | 3 |
two weeks | 3 |
vertical transmission | 3 |
three independent | 3 |
positive test | 3 |
human seasonal | 3 |
current study | 3 |
also known | 3 |
using viral | 3 |
irf translocation | 3 |
ace shedding | 3 |
conserved epitope | 3 |
hydrogen bonds | 3 |
clinical benefit | 3 |
viral pathogen | 3 |
probe design | 3 |
using one | 3 |
may spread | 3 |
stomatitis virus | 3 |
hepg cells | 3 |
aiv subtypes | 3 |
high risk | 3 |
south korean | 3 |
doublestranded rna | 3 |
th august | 3 |
direct interaction | 3 |
associated diseases | 3 |
inducible nitric | 3 |
capsid proteins | 3 |
nab complex | 3 |
second antibody | 3 |
sequence variations | 3 |
study provides | 3 |
late promoter | 3 |
research groups | 3 |
cov strain | 3 |
protein contains | 3 |
specific anti | 3 |
baseline characteristics | 3 |
term cell | 3 |
abidol hydrochloride | 3 |
specific igg | 3 |
life technologies | 3 |
total cellular | 3 |
small animal | 3 |
internal control | 3 |
coronavirus rna | 3 |
respiratory infection | 3 |
wt mice | 3 |
interfering rna | 3 |
nps aliquot | 3 |
kindly provided | 3 |
institut pasteur | 3 |
pseudovirus entry | 3 |
different coronaviruses | 3 |
clinical presentation | 3 |
inhibits stress | 3 |
mouse th | 3 |
creative commons | 3 |
sg nucleation | 3 |
hcv biology | 3 |
african green | 3 |
small interfering | 3 |
mild cases | 3 |
envelope proteins | 3 |
interferon production | 3 |
current research | 3 |
fever clinical | 3 |
infectious pathogens | 3 |
important antiviral | 3 |
total nps | 3 |
china acknowledgements | 3 |
chinese center | 3 |
future plans | 3 |
health interventions | 3 |
andmouth disease | 3 |
gene transfer | 3 |
mass spectrometry | 3 |
molecular diagnosis | 3 |
cellular mrnas | 3 |
tubulin antibodies | 3 |
fetal death | 3 |
transcriptional gene | 3 |
primary inflammatory | 3 |
commonly used | 3 |
cells established | 3 |
first two | 3 |
protein also | 3 |
super spreading | 3 |
rabbit igg | 3 |
help understand | 3 |
human angiotensin | 3 |
transferred onto | 3 |
autonomous region | 3 |
culture plates | 3 |
also used | 3 |
slightly serious | 3 |
signal transduction | 3 |
flua pandemic | 3 |
might help | 3 |
cellular genes | 3 |
candidate vaccine | 3 |
host species | 3 |
amplification efficiency | 3 |
intrapulmonary bronchial | 3 |
chimeric genomes | 3 |
ns plasmid | 3 |
agarose gel | 3 |
causing human | 3 |
autopsy cases | 3 |
inhibits translation | 3 |
blot analysis | 3 |
ifn antagonism | 3 |
small rnas | 3 |
tbk ikk | 3 |
cytopathic effects | 3 |
translation inhibition | 3 |
west nile | 3 |
nitrocellulose membrane | 3 |
antiviral therapy | 3 |
lung inflammation | 3 |
australian hajj | 3 |
influenza strains | 3 |
ge healthcare | 3 |
excellent specificity | 3 |
either empty | 3 |
critical cases | 3 |
multiple cloning | 3 |
moderately serious | 3 |
igg complex | 3 |
tour group | 3 |
sialic acid | 3 |
sars model | 3 |
ha protein | 3 |
widened alveolar | 3 |
region ii | 3 |
cell proteins | 3 |
study showed | 3 |
sp myeloma | 3 |
growth curves | 3 |
enp vs | 3 |
community outbreak | 3 |
productive infection | 3 |
rapid viral | 3 |
two sars | 3 |
renal disease | 3 |
valuable tool | 3 |
lead compound | 3 |
cov enzyme | 3 |
pulmonary imaging | 3 |
placental barrier | 3 |
regulatory factor | 3 |
renmin hospital | 3 |
nylon membrane | 3 |
pneumonia patients | 3 |
wide range | 3 |
infected population | 3 |
viral disease | 3 |
using foci | 3 |
stalled translation | 3 |
leader sequence | 3 |
pulmonary inflammation | 3 |
protein induces | 3 |
also found | 3 |
using rt | 3 |
mean age | 3 |
humoral response | 3 |
stress responses | 3 |
dna copy | 3 |
epidemic trend | 3 |
viral cultures | 3 |
coding sequence | 3 |
square test | 3 |
viruses carrying | 3 |
two days | 3 |
nucleoside reverse | 3 |
recent outbreak | 3 |
performed according | 3 |
infection also | 3 |
hyaline membrane | 3 |
contains two | 3 |
hpv life | 3 |
dashed lines | 3 |
patients acknowledgements | 3 |
hpv types | 3 |
infection process | 3 |
viral suppressors | 3 |
standard deviation | 3 |
protein nsp | 3 |
medicine tanreqing | 3 |
terminal residues | 3 |
two structures | 3 |
nuclear export | 3 |
ct findings | 3 |
four parallel | 3 |
infectious human | 3 |
thumb domain | 3 |
virus entry | 3 |
one patient | 3 |
models may | 3 |
facilitate viral | 3 |
expression vector | 3 |
secondary bacterial | 3 |
rabbit serum | 3 |
cases reported | 3 |
replication complex | 3 |
elispot assay | 3 |
pig kidney | 3 |
ace rabbit | 3 |
chinese government | 3 |
vaccine candidates | 3 |
polymerase involved | 3 |
contributed equally | 3 |
proteins tia | 3 |
encoding multiple | 3 |
viral duration | 3 |
capsid genes | 3 |
highly expressed | 3 |
health problem | 3 |
helicase domain | 3 |
clinically approved | 3 |
seventeen isolates | 3 |
cells form | 3 |
van riel | 3 |
three mice | 3 |
cultured cells | 3 |
carbonyl oxygen | 3 |
showed similar | 3 |
family members | 3 |
malignant cells | 3 |
acid replacement | 3 |
statistical analyses | 3 |
mediated isothermal | 3 |
murine hepatitis | 3 |
evolutionarily conserved | 3 |
color change | 3 |
sl rna | 3 |
descriptive study | 3 |
increased fluorescence | 3 |
visual detection | 3 |
significant neutralizing | 3 |
encode viral | 3 |
final volume | 3 |
horseshoe bats | 3 |
selective inhibitors | 3 |
publicly available | 3 |
cultures provide | 3 |
microcarrier beads | 3 |
pb assembly | 3 |
median length | 3 |
one nps | 3 |
fi nal | 3 |
novel platform | 3 |
hydrophobic interactions | 3 |
understanding sars | 3 |
borne hcv | 3 |
organ dysfunction | 3 |
forming unit | 3 |
virtual screening | 3 |
drug screening | 3 |
cp transfusion | 3 |
highly variable | 3 |
production induced | 3 |
human rabies | 3 |
dennis lo | 3 |
also provide | 3 |
much longer | 3 |
tlr family | 3 |
adult human | 3 |
expressing ha | 3 |
primer pairs | 3 |
conformational change | 3 |
enzymatic assays | 3 |
murine sars | 3 |
new england | 3 |
patients showed | 3 |
hospitalized patients | 3 |
drinking raw | 3 |
affinity chromatography | 3 |
virological research | 3 |
viral internal | 3 |
induced silencing | 3 |
pv strain | 3 |
animal studies | 3 |
less severe | 3 |
effective treatment | 3 |
parallel wells | 3 |
ii assay | 3 |
transcription loop | 3 |
dna vaccine | 3 |
inhibits type | 3 |
including influenza | 3 |
puerto rico | 3 |
individuals infected | 3 |
buffer mmol | 3 |
may develop | 3 |
main protease | 3 |
induces sg | 3 |
determined using | 3 |
mainly include | 3 |
initial velocities | 3 |
acute renal | 3 |
associated disease | 3 |
internal genes | 3 |
cerebrospinal fluid | 3 |
tissue damage | 3 |
recovered patients | 3 |
low level | 3 |
correspondence analysis | 3 |
studying viral | 3 |
logistic regression | 3 |
human lung | 3 |
natural reservoirs | 3 |
extracellular domain | 3 |
brain stem | 3 |
virus envelope | 3 |
copies ml | 3 |
vaccine expressing | 3 |
induced apoptosis | 3 |
serially diluted | 3 |
cruz biotechnology | 3 |
ii multiplex | 3 |
clinical disease | 3 |
multiple vsrs | 3 |
toward inducing | 3 |
np gene | 3 |
airway epithelial | 3 |
received cp | 3 |
traced back | 3 |
maximum likelihood | 3 |
coronavirus replicase | 3 |
microculture neutralization | 3 |
prevent cov | 3 |
spanish influenza | 3 |
prediction limit | 3 |
stranded rnas | 3 |
transmission potential | 3 |
novel recombinant | 3 |
pcr possessed | 3 |
many different | 3 |
containing serum | 3 |
mice deficient | 3 |
rnase inhibitor | 3 |
structural studies | 3 |
igm antibody | 3 |
pathogen interactions | 3 |
complete hadv | 3 |
might explain | 3 |
binding domains | 3 |
eukaryotic cells | 3 |
sindbis virus | 3 |
million people | 3 |
models used | 3 |
vaccine design | 3 |
sequence similarity | 3 |
ace interaction | 3 |
pb component | 3 |
inhibitory effect | 3 |
coli bj | 3 |
i restriction | 3 |
viruses must | 3 |
first report | 3 |
antiviral rna | 3 |
silencing assay | 3 |
cytokines including | 3 |
sirna production | 3 |
study period | 3 |
around twofold | 3 |
viral pneumonia | 3 |
antiviral stress | 3 |
china cdc | 3 |
parental strain | 3 |
van reeth | 3 |
seasonal human | 3 |
surface ha | 3 |
huh cell | 3 |
protein synthesis | 3 |
disease onset | 3 |
dengue infection | 3 |
primary cells | 3 |
region iii | 3 |
diabetes mellitus | 3 |
nt dig | 3 |
hubei province | 3 |
originally isolated | 3 |
cellular immunity | 3 |
nasopharyngeal swab | 3 |
based vaccine | 3 |
ace function | 3 |
effective antiviral | 3 |
supplementary table | 3 |
multiplex resplex | 3 |
acid sequence | 3 |
severe diseases | 3 |
cytoplasmic processing | 3 |
human bronchial | 3 |
fever complicated | 3 |
rnai induced | 3 |
dengue fever | 3 |
nasal epithelial | 3 |
dna copies | 3 |
also showed | 3 |
median interval | 3 |
atypical pathogens | 3 |
immune sensors | 3 |
coronavirus accessory | 3 |
virion assembly | 3 |
complex may | 3 |
korea cdc | 3 |
zoonotic potential | 3 |
strains isolated | 3 |
human epithelial | 3 |
hbeag secretion | 3 |
human cell | 3 |
inducible gene | 3 |
adaptor protein | 3 |
white blood | 3 |
inoculation immunization | 3 |
detected using | 3 |
pregnant patients | 3 |
baculovirus expression | 3 |
group received | 3 |
various truncated | 3 |
virus growth | 3 |
vaccine induces | 3 |
acid extraction | 3 |
different steps | 3 |
ray crystallographic | 3 |
phosphorylated eif | 3 |
surveillance system | 3 |
using magnetic | 3 |
commercial pig | 3 |
dependent manner | 3 |
resulting plasmids | 3 |
vesicular stomatitis | 3 |
vascular permeability | 3 |
terminal cards | 3 |
develop universal | 3 |
catalytic domain | 3 |
adenovirus rad | 3 |
humanized mice | 3 |
infectious cdna | 3 |
mild symptoms | 3 |
retrospective cohort | 3 |
discharged patients | 3 |
viral mrnas | 3 |
virus date | 3 |
gel shift | 3 |
lopinavir ritonavir | 3 |
protein promotes | 3 |
interferon receptor | 3 |
plaque size | 3 |
will provide | 3 |
cov might | 3 |
nephropathia epidemica | 3 |
virus detection | 3 |
replication sites | 3 |
cat kidney | 3 |
established mouse | 3 |
existing medical | 3 |
china novel | 3 |
important roles | 3 |
clinical trials | 3 |
might contribute | 3 |
phyllanthus emblica | 3 |
studies revealed | 3 |
exfoliated epithelial | 3 |
organoid cultures | 3 |
zinc ion | 3 |
serious health | 3 |
infection may | 3 |
sars epidemic | 3 |
compound named | 3 |
real time | 3 |
multiple organ | 3 |
recent studies | 3 |
cov plpro | 3 |
pasteurella multocida | 3 |
several limitations | 3 |
membrane matrix | 3 |
third dimension | 3 |
culture medium | 3 |
ifn signaling | 3 |
health emergency | 3 |
parainfluenza viral | 3 |
future direction | 3 |
critical role | 3 |
possessed specificities | 3 |
infectious bronchitis | 3 |
type hadv | 3 |
viruses may | 3 |
suppressing rnai | 3 |
pr challenge | 3 |
conserved residues | 3 |
lysis buffer | 3 |
cells showed | 3 |
results indicated | 3 |
may lead | 3 |
rna copy | 3 |
haemorrhagic fever | 3 |
interstitial pneumonia | 3 |
first antibody | 3 |
therapeutic tools | 3 |
risc assembly | 3 |
cellular response | 3 |
murine model | 3 |
total volume | 3 |
efficiently infected | 3 |
genomic analysis | 3 |
protective role | 3 |
virus production | 3 |
newly emerged | 3 |
cellular receptor | 3 |
muscle pain | 3 |
cov biology | 3 |
clinical diagnosis | 3 |
mov inhibits | 3 |
accession numbers | 3 |
like receptor | 3 |
subgenomic mrnas | 2 |
action points | 2 |
palm civet | 2 |
multicellular complexity | 2 |
different hosts | 2 |
virus ljb | 2 |
postulates fulfilled | 2 |
research team | 2 |
immune epitope | 2 |
neutralizing monoclonal | 2 |
virus assembly | 2 |
ddr response | 2 |
sars virus | 2 |
deubiquitinating enzyme | 2 |
highly selective | 2 |
poct diagnosis | 2 |
previous reports | 2 |
hbeag levels | 2 |
viral oncogenes | 2 |
mosquito vectors | 2 |
several multiplex | 2 |
mortality rates | 2 |
either inoculated | 2 |
chain carbonyl | 2 |
indicated time | 2 |
complex binding | 2 |
whether ev | 2 |
seroconversion time | 2 |
ch hljh | 2 |
associated kidney | 2 |
rotavirus induces | 2 |
moderate cases | 2 |
white selection | 2 |
encoding ns | 2 |
bryan cullen | 2 |
adequately reproduce | 2 |
mcs models | 2 |
medium containing | 2 |
group correspondence | 2 |
primary kptecs | 2 |
macromolecular crystallography | 2 |
mouse monoclonal | 2 |
effi cacy | 2 |
poorer clinical | 2 |
antiviral activities | 2 |
effective prevention | 2 |
i mda | 2 |
open access | 2 |
although many | 2 |
structural core | 2 |
mtor signaling | 2 |
infected cases | 2 |
electron density | 2 |
failure including | 2 |
infected pneumonia | 2 |
amplifi cation | 2 |
diagnostic tests | 2 |
rabies glycoprotein | 2 |
post inoculation | 2 |
cancer interaction | 2 |
hpv chimeric | 2 |
good prognosis | 2 |
sentinel surveillance | 2 |
diagnosis reagents | 2 |
reported globally | 2 |
expressing ace | 2 |
therapy including | 2 |
blood transfusion | 2 |
still positive | 2 |
protect animals | 2 |
markov model | 2 |
like coronavirus | 2 |
zikv infection | 2 |
cells represent | 2 |
hexon genes | 2 |
blood sample | 2 |
adenovirus replication | 2 |
produce infectious | 2 |
particular risk | 2 |
potential risk | 2 |
animals positive | 2 |
suspected mers | 2 |
two major | 2 |
widespread attention | 2 |
national guidelines | 2 |
protein interactions | 2 |
sars patients | 2 |
also play | 2 |
columns show | 2 |
antiviral actions | 2 |
polyprotein processing | 2 |
virus vp | 2 |
simple operation | 2 |
hbv dna | 2 |
acid recovery | 2 |
early outbreak | 2 |
novel visual | 2 |
fibrin deposition | 2 |
cesarean section | 2 |
detection bias | 2 |
epitheliotropic viruses | 2 |
replicate efficiently | 2 |
hilar bronchus | 2 |
cells display | 2 |
primary cause | 2 |
virus load | 2 |
adding ace | 2 |
pcr reaction | 2 |
nuclear mrna | 2 |
binding specificity | 2 |
findings indicate | 2 |
reported studies | 2 |
trailer rna | 2 |
cd epitopes | 2 |
vitro transcribed | 2 |
serological testing | 2 |
rnai suppressor | 2 |
specific primers | 2 |
kit possesses | 2 |
group died | 2 |
prokaryotic expression | 2 |
culture vaccine | 2 |
prevent severe | 2 |
including humans | 2 |
kidney tubule | 2 |
array detection | 2 |
first infusion | 2 |
study influenza | 2 |
palm civets | 2 |
main target | 2 |
normal range | 2 |
multiple sequence | 2 |
include various | 2 |
infectious clone | 2 |
higher antibody | 2 |
diffuse alveolar | 2 |
ray structure | 2 |
kinetic assay | 2 |
amplification method | 2 |
magnetic cell | 2 |
developing regions | 2 |
biological function | 2 |
imaging improvement | 2 |
analyzed data | 2 |
currently available | 2 |
qiaquick gel | 2 |
live pedv | 2 |
human hepatoma | 2 |
may stimulate | 2 |
influenza nucleoprotein | 2 |
remove isg | 2 |
alveolar epithelium | 2 |
laboratory abnormalities | 2 |
copy per | 2 |
virus pb | 2 |
provide cross | 2 |
wide host | 2 |
camel products | 2 |
kidney diseases | 2 |
viral lower | 2 |
like assemblies | 2 |
models will | 2 |
connect virologists | 2 |
blue dye | 2 |
homologous regions | 2 |
similar inflammatory | 2 |
treat patients | 2 |
hcv core | 2 |
responses include | 2 |
organoids compared | 2 |
tissues including | 2 |
mrna precursor | 2 |
proteins function | 2 |
patent medicine | 2 |
chemically synthesized | 2 |
commercial systems | 2 |
three passages | 2 |
wuhan outbreak | 2 |
virion incorporation | 2 |
decline zone | 2 |
reference strain | 2 |
time point | 2 |
initial screen | 2 |
important target | 2 |
expressing np | 2 |
pneumonia outbreak | 2 |
normal lung | 2 |
mice died | 2 |
care settings | 2 |
neutralizing epitope | 2 |
specialized hospital | 2 |
primary keratinocytes | 2 |
years group | 2 |
mouth epidemic | 2 |
epidemic calls | 2 |
middle part | 2 |
complex mers | 2 |
neurological manifestations | 2 |
sequence comparisons | 2 |
group within | 2 |
four times | 2 |
nasal swabs | 2 |
based influenza | 2 |
serological evidence | 2 |
emerging infections | 2 |
robust immunity | 2 |
table shows | 2 |
amplification condition | 2 |
two proteins | 2 |
percentage decreased | 2 |
primate species | 2 |
acquired immune | 2 |
nonhuman primate | 2 |
intestinal epithelial | 2 |
specific monoclonal | 2 |
protective efficacy | 2 |
dynamic interaction | 2 |
gene segments | 2 |
virus influenza | 2 |
core complex | 2 |
different tissues | 2 |
artificial neural | 2 |
nucleoprotein derived | 2 |
decahydroisoquinolin scaffold | 2 |
plaque variants | 2 |
viral proteinase | 2 |
also induces | 2 |
without changing | 2 |
explored factors | 2 |
induced activation | 2 |
nucleotide excision | 2 |
er stress | 2 |
specimen process | 2 |
xray structural | 2 |
prime inoculation | 2 |
immune deficiency | 2 |
dynamic characteristics | 2 |
severe consequences | 2 |
dimensional radial | 2 |
zoonotic origin | 2 |
specimens including | 2 |
sp cells | 2 |
dig antibody | 2 |
methylprednisolone mg | 2 |
similar research | 2 |
fetal malformations | 2 |
sulfate precipitation | 2 |
alveolar damage | 2 |
within weeks | 2 |
different expression | 2 |
within two | 2 |
search model | 2 |
new cases | 2 |
first week | 2 |
technology might | 2 |
also identified | 2 |
sequence information | 2 |
fidelity dna | 2 |
ns proteins | 2 |
substrate concentration | 2 |
severe patients | 2 |
crispr cas | 2 |
also cause | 2 |
nextgeneration sequencing | 2 |
consecutive years | 2 |
pathogenic virus | 2 |
model analysis | 2 |
highly efficient | 2 |
embryonated chicken | 2 |
outbreak investigation | 2 |
published sequences | 2 |
symptomatic patients | 2 |
human cd | 2 |
tract human | 2 |
groups underwent | 2 |
quantitatively detect | 2 |
major cause | 2 |
commercially available | 2 |
endosomal pathway | 2 |
peritonitis virus | 2 |
different nonhuman | 2 |
rapid weight | 2 |
million deaths | 2 |
encodes orf | 2 |
adenovirus infections | 2 |
pb segment | 2 |
response including | 2 |
high shear | 2 |
throat swab | 2 |
dual infections | 2 |
fi nishing | 2 |
priority research | 2 |
across species | 2 |
antibody detection | 2 |
epidemic strains | 2 |
ternary complex | 2 |
new knowledge | 2 |
two strains | 2 |
coronavirus cell | 2 |
enterovirus infection | 2 |
viral regulation | 2 |
blood products | 2 |
review committee | 2 |
acid precipitation | 2 |
natural products | 2 |
target antigens | 2 |
lung impairment | 2 |
conditions like | 2 |
therapeutic interventions | 2 |
glycoprotein ligand | 2 |
neural progenitor | 2 |
age years | 2 |
large population | 2 |
model also | 2 |
target enriched | 2 |
pb core | 2 |
screen reveals | 2 |
seov infection | 2 |
neutrophil numbers | 2 |
secondary cases | 2 |
fatal inflammatory | 2 |
emerged middle | 2 |
resembles self | 2 |
cellular responses | 2 |
cellular models | 2 |
specific role | 2 |
online rna | 2 |
vaccine provides | 2 |
previous observations | 2 |
based methods | 2 |
suspension array | 2 |
adult inpatients | 2 |
coli dh | 2 |
binds argonaute | 2 |
organ damage | 2 |
evade host | 2 |
antiviral state | 2 |
high fever | 2 |
various number | 2 |
aa identity | 2 |
restriction maps | 2 |
virus expressing | 2 |
escherichia coli | 2 |
week old | 2 |
virus interacts | 2 |
conserved asp | 2 |
deadly hcovs | 2 |
grey dots | 2 |
structure protein | 2 |
cresol red | 2 |
renal insufficiency | 2 |
infectious hcv | 2 |
milk secretion | 2 |
well tissue | 2 |
described elsewhere | 2 |
blood cell | 2 |
first three | 2 |
diffraction data | 2 |
dependent cell | 2 |
cytokine production | 2 |
pilgrims reported | 2 |
fever subsided | 2 |
culture conditions | 2 |
infectious hepatitis | 2 |
international spread | 2 |
hbv activity | 2 |
multiplexing rt | 2 |
represented one | 2 |
also confirmed | 2 |
i sg | 2 |
growth curve | 2 |
fragment containing | 2 |
chest distress | 2 |
septic shock | 2 |
transmembrane proteins | 2 |
antigen detection | 2 |
prdc results | 2 |
serial ct | 2 |
similar replicative | 2 |
findings provide | 2 |
reproducible results | 2 |
life river | 2 |
pig populations | 2 |
fold higher | 2 |
two parts | 2 |
high degree | 2 |
also analyzed | 2 |
virus transmitted | 2 |
cellular aggregates | 2 |
following infection | 2 |
targeted inhibition | 2 |
membrane formation | 2 |
mass media | 2 |
first century | 2 |
urgent need | 2 |
organotypic cultures | 2 |
asymptomatic contact | 2 |
acid detection | 2 |
performed using | 2 |
cov drug | 2 |
cyclooxygenase expression | 2 |
tumor progression | 2 |
preemptive approach | 2 |
precursor processing | 2 |
various times | 2 |
cases show | 2 |
vital river | 2 |
pkr dimerization | 2 |
cov knowledge | 2 |
early late | 2 |
river laboratory | 2 |
isg genes | 2 |
per reaction | 2 |
lung parenchyma | 2 |
chinese horseshoe | 2 |
protein vaccines | 2 |
human case | 2 |
hydrophobic patch | 2 |
common viral | 2 |
worth noting | 2 |
bovine coronavirus | 2 |
igg polymers | 2 |
future development | 2 |
rna loads | 2 |
electronic medical | 2 |
classical pathway | 2 |
reprogrammed human | 2 |
later stage | 2 |
host translation | 2 |
imposes stress | 2 |
ifn pathway | 2 |
congenital heart | 2 |
hbx gene | 2 |
protein specifically | 2 |
recent emergence | 2 |
complicating pregnancy | 2 |
th days | 2 |
ii panel | 2 |
improve basic | 2 |
drink raw | 2 |
avian viruses | 2 |
viral evasion | 2 |
variation trend | 2 |
prothrombinase fibroleukin | 2 |
patients diagnosed | 2 |
stimulate cd | 2 |
cov nucleocapsid | 2 |
health problems | 2 |
mutational analysis | 2 |
species boundaries | 2 |
rna might | 2 |
main goal | 2 |
conventional influenza | 2 |
megalin cubilin | 2 |
two overlapping | 2 |
analysis confirmed | 2 |
positively expressed | 2 |
major swine | 2 |
magnetic particle | 2 |
traditional cancer | 2 |
slightly concerned | 2 |
mdck cells | 2 |
lytic infection | 2 |
feline caliciviruses | 2 |
international concern | 2 |
engineering protein | 2 |
shock syndrome | 2 |
reported sars | 2 |
virus nucleoproteins | 2 |
endogenous peroxidase | 2 |
fi ndings | 2 |
effective vaccine | 2 |
early events | 2 |
novel mammalian | 2 |
deadly covs | 2 |
basic training | 2 |
cytokine responses | 2 |
distinct severe | 2 |
organ cultures | 2 |
longer time | 2 |
provided evidence | 2 |
levitation method | 2 |
lethal diseases | 2 |
simulated microgravity | 2 |
virus hijacks | 2 |
asian genotype | 2 |
result showed | 2 |
human virus | 2 |
varicella zoster | 2 |
faster decline | 2 |
measles virus | 2 |
bats may | 2 |
one month | 2 |
spike gene | 2 |
existing humoral | 2 |
different extents | 2 |
human plasmacytoid | 2 |
genomic sequences | 2 |
zhejiang province | 2 |
cellular receptors | 2 |
tissue sections | 2 |
urgent treatment | 2 |
sampling time | 2 |
different topics | 2 |
swine flu | 2 |
wuhan nodavirus | 2 |
ten days | 2 |
brome mosaic | 2 |
per well | 2 |
containing four | 2 |
positive proportion | 2 |
confers heterosubtypic | 2 |
colorimetric lamp | 2 |
positive clones | 2 |
analyzing spheroids | 2 |
subcellular localization | 2 |
cov infected | 2 |
primary antibodies | 2 |
fbwz oxp | 2 |
hamster kidney | 2 |
point mutations | 2 |
intramuscular groups | 2 |
affect viral | 2 |
partially understood | 2 |
various types | 2 |
virus ankara | 2 |
population doublings | 2 |
immunological characteristics | 2 |
different viral | 2 |
foci sizes | 2 |
ml dapi | 2 |
hbv infection | 2 |
response plays | 2 |
intranasal administration | 2 |
used drugs | 2 |
producing infectious | 2 |
observing cytopathic | 2 |
developing severe | 2 |
inhibitor binding | 2 |
clinical progression | 2 |
spleen mononuclear | 2 |
neurological conditions | 2 |
enriched multiplexing | 2 |
emerging coronaviruses | 2 |
coronavirus replication | 2 |
people around | 2 |
original clinical | 2 |
ml cscl | 2 |
igg level | 2 |
coronavirus group | 2 |
downstream effectors | 2 |
pro shows | 2 |
human alveolar | 2 |
tyrosine kinases | 2 |
available viruses | 2 |
technologies corporation | 2 |
deisgylating activities | 2 |
activities towards | 2 |
great interest | 2 |
viral strain | 2 |
missing links | 2 |
will focus | 2 |
macrophages infected | 2 |
form colonies | 2 |
kinetic curves | 2 |
potential tool | 2 |
findings show | 2 |
originally designed | 2 |
ajolu rh | 2 |
case detection | 2 |
mortality within | 2 |
nucleocapsid proteins | 2 |
multicellular tumor | 2 |
slightly lower | 2 |
also positive | 2 |
respiratory adenoviruses | 2 |
fusion cells | 2 |
mrna degradation | 2 |
studies involving | 2 |
monomer switch | 2 |
competent mutants | 2 |
also shown | 2 |
initial incubation | 2 |
cov epidemic | 2 |
routine covid | 2 |
placental transmission | 2 |
ago via | 2 |
normal ranges | 2 |
ev receptors | 2 |
cov stains | 2 |
moderate symptoms | 2 |
derived small | 2 |
pandemic spread | 2 |
reassortant virus | 2 |
nonproductive infection | 2 |
vaccine approved | 2 |
eagle medium | 2 |
cosmopolitan genotype | 2 |
disease modeling | 2 |
mice without | 2 |
ub comprises | 2 |
based devices | 2 |
two types | 2 |
high potency | 2 |
mouse lethal | 2 |
encoded proteins | 2 |
protective antibody | 2 |
splicing factor | 2 |
foci reduction | 2 |
serologic tests | 2 |
compensatory emphysema | 2 |
tract samples | 2 |
linked immunospot | 2 |
kristina broliden | 2 |
wasting syndrome | 2 |
vaccinia ankara | 2 |
risk level | 2 |
host factors | 2 |
independent experiments | 2 |
cells directed | 2 |
dimensional keratinocyte | 2 |
mathematical modelling | 2 |
genetic variation | 2 |
inflammatory drugs | 2 |
different mechanisms | 2 |
aspartate aminotransferase | 2 |
mainly focus | 2 |
expressed successfully | 2 |
inhibitor lopinavir | 2 |
also induced | 2 |
virus segment | 2 |
hiv nucleoside | 2 |
yellow fever | 2 |
syndrome inhibitor | 2 |
cell system | 2 |
human gamma | 2 |
protein complex | 2 |
antiviral signaling | 2 |
rapid increase | 2 |
deficiency syndrome | 2 |
plasmid prad | 2 |
coding region | 2 |
necrotizing enteritis | 2 |
metagenomic nextgeneration | 2 |
host epithelial | 2 |
impacts stress | 2 |
median age | 2 |
pseudoviruses showed | 2 |
strong antibody | 2 |
many viral | 2 |
transmembrane serine | 2 |
human neurons | 2 |
structural insights | 2 |
viruses expressing | 2 |
detection limits | 2 |
np fusion | 2 |
tandem repeats | 2 |
adenovirus types | 2 |
tumor spheroid | 2 |
rapid classification | 2 |
dual inhibitors | 2 |
different genotypes | 2 |
key target | 2 |
disease outbreak | 2 |
possible mechanism | 2 |
peroxidase labeled | 2 |
rodent hosts | 2 |
viral receptors | 2 |
better replication | 2 |
cell populations | 2 |
oncolytic viruses | 2 |
therapy protocols | 2 |
specific receptors | 2 |
similar clinical | 2 |
attenuated adenovirus | 2 |
nsp complex | 2 |
typical clinical | 2 |
optimized suspension | 2 |
targeting cov | 2 |
cr technology | 2 |
given human | 2 |
screening antiviral | 2 |
targeting coronavirus | 2 |
gene contributes | 2 |
direct immunofluorescence | 2 |
like polarized | 2 |
species specific | 2 |
early february | 2 |
efficient propagation | 2 |
bat covs | 2 |
ns wt | 2 |
possible underlying | 2 |
fatal acute | 2 |
dicer cleavage | 2 |
bronchial lavage | 2 |
pseudovirion infection | 2 |
two covid | 2 |
sensitivities correlated | 2 |
encoding hcv | 2 |
assay sensitivities | 2 |
high titers | 2 |
rna transcription | 2 |
protein complexes | 2 |
immune signaling | 2 |
warmstart colorimetric | 2 |
urological system | 2 |
recent pneumonia | 2 |
activation may | 2 |
cellular entry | 2 |
rna sensor | 2 |
western blots | 2 |
enormous threat | 2 |
histopathological changes | 2 |
new technologies | 2 |
rna stress | 2 |
vaccine rad | 2 |
blood donors | 2 |
prospective study | 2 |
associated virus | 2 |
culture using | 2 |
high affinity | 2 |
viral cellular | 2 |
valle del | 2 |
attack rate | 2 |
reactive hyperplasia | 2 |
hcv rna | 2 |